TSI Pharmaceuticals was established as NPD (New Products Development) in 1988 in Brisbane, Australia, and has grown to supply and package an extensive range of non-scheduled, complementary, listed and registered products. Its versatility offers products in a range of formats including uncoated or coated tablets, softgels and hard two-piece gelatin and vegetarian capsules of all sizes.
In 2011 NPD formed a strategic partnership with TSI Health Sciences® a premium producer of pharmaceutical / OTC / supplement grade glucosamine and chondroitin. The company operates four cGMP manufacturing facilities, customer service offices worldwide and a 60-acre fully integrated manufacturing, research and Quality Assurance campus. TSI Health Sciences® works with clients in more than eight countries.
As a major shareholder in NPD, TSI Health Sciences® helps maintain the high standards set by NPD over more than two decades. This partnership also provides us with access to worldwide innovation, economic purchasing and the vertical integration of closely controlled raw material manufacturers.
NPD changed its name to TSI Pharmaceuticals in July 2012, to align more closely with its parent company.